tiprankstipranks
Advertisement
Advertisement
Imugene Issues 35.4 Million New Shares in ASX Placement
PremiumCompany AnnouncementsImugene Issues 35.4 Million New Shares in ASX Placement
14d ago
Imugene Seeks ASX Quotation for 35.4 Million New Shares
Premium
Company Announcements
Imugene Seeks ASX Quotation for 35.4 Million New Shares
14d ago
Imugene Issues Additional Unquoted Options Under Existing Equity Arrangements
Premium
Company Announcements
Imugene Issues Additional Unquoted Options Under Existing Equity Arrangements
15d ago
Imugene Issues Additional Unquoted Options Under Capital Management Plan
PremiumCompany AnnouncementsImugene Issues Additional Unquoted Options Under Capital Management Plan
22d ago
Imugene Seeks ASX Quotation for Additional Ordinary Shares
Premium
Company Announcements
Imugene Seeks ASX Quotation for Additional Ordinary Shares
22d ago
Imugene outlines non-underwritten capital raising with strict offer restrictions
Premium
Company Announcements
Imugene outlines non-underwritten capital raising with strict offer restrictions
23d ago
Imugene Seeks Trading Halt Ahead of Capital Raising Announcement
PremiumCompany AnnouncementsImugene Seeks Trading Halt Ahead of Capital Raising Announcement
24d ago
Imugene’s VAXINIA Trial Termination: What the Latest Clinical Update Means for IUGNF Investors
Premium
Company Announcements
Imugene’s VAXINIA Trial Termination: What the Latest Clinical Update Means for IUGNF Investors
28d ago
Imugene’s OASIS Trial Termination: What It Means for IUGNF Investors
Premium
Company Announcements
Imugene’s OASIS Trial Termination: What It Means for IUGNF Investors
28d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100